Inactive protein-arginine deiminase type-6

BE0002313ProteinHumansPADI6

Structural constituent of cytoplasmic lattices, which plays a key role in early embryonic development (PubMed:37922900, PubMed:41772195). It is acted on by 1 drug in DrugBank.

Gene name
PADI6
UniProtKB entry
Q6TGC4Swiss-Prot
Cellular location
Cytoplasm
Residues / weight
694 residues · 77,727 Da
Also known as
hPADVI · PAD6 · Peptidyl arginine deiminase-like protein · Peptidylarginine deiminase VI · Protein-arginine deiminase type VI

Resolves to

Protein
UniProtQ6TGC4UniProt namePADI6_HUMAN
Gene
HGNCHGNC:20449NCBI Gene353238GenBank40068449GeneCardsPADI6
Pharmacology
KEGGhsa:353238
Structure
PDB4DATPDB4DAUPDB8QL0
Drugs

What you can answer from here — as of February 11, 2025

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
9GO termsFunction, process and component, as structured annotations
Sign in
3Pfam domainsDomain architecture mapped to Pfam families and clans
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Inactive protein-arginine deiminase type-6, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In